Experience

Phoenix PharmaLabs, Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chairman, Chief Medicinal Chemist, Founder

  • Jan 2001 - Present

  Phoenix PharmaLabs, Inc. (PPL) is a preclinical drug discovery company focused on the development of new potent, safe, non-addictive treatments for pain and addiction. PPL has developed and acquired novel families of New Molecular Entity (NME) ligands that just partially stimulate the receptors in a much more balanced manner or in other novel ways. These discoveries have resulted in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side… Show more Phoenix PharmaLabs, Inc. (PPL) is a preclinical drug discovery company focused on the development of new potent, safe, non-addictive treatments for pain and addiction. PPL has developed and acquired novel families of New Molecular Entity (NME) ligands that just partially stimulate the receptors in a much more balanced manner or in other novel ways. These discoveries have resulted in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side effects. Show less Phoenix PharmaLabs, Inc. (PPL) is a preclinical drug discovery company focused on the development of new potent, safe, non-addictive treatments for pain and addiction. PPL has developed and acquired novel families of New Molecular Entity (NME) ligands that just partially stimulate the receptors in a much more balanced manner or in other novel ways. These discoveries have resulted in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side… Show more Phoenix PharmaLabs, Inc. (PPL) is a preclinical drug discovery company focused on the development of new potent, safe, non-addictive treatments for pain and addiction. PPL has developed and acquired novel families of New Molecular Entity (NME) ligands that just partially stimulate the receptors in a much more balanced manner or in other novel ways. These discoveries have resulted in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side effects. Show less


Utah State University
• Higher Education
• 700 & Above Employee
• Visiting Professor

  • Jun 2005 - Apr 2016

SynVax Pharmaceuticals, Inc.
• United States
• Research
• Senior Medicinal Chemist

  • Jan 1997 - Oct 2000

SRI International
• India
• Higher Education
• 1 - 100 Employee
• Senior Medicinal Chemist

  • Apr 1972 - Jul 1995